| Mrs Linda Ly, PHARMD | |
|
8415 Waverly Dr, Buena Park, CA 90621-1050 | |
| (714) 228-9288 | |
| Not Available |
| Full Name | Mrs Linda Ly |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 8415 Waverly Dr, Buena Park, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154570661 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH44788 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Linda Ly, PHARMD 8415 Waverly Dr, Buena Park, CA 90621-1050 Ph: (714) 228-9288 | Mrs Linda Ly, PHARMD 8415 Waverly Dr, Buena Park, CA 90621-1050 Ph: (714) 228-9288 |
News Archive
Painkillers prescribed by doctors are the starting point for an opioid addiction for more than half of female methadone clinic patients, and they need different treatment from men with addiction, says a study led by McMaster University researchers.
The world's biggest burger chain lobbied Congress, the White House, the Department of Labor and the Department of Health and Human Services on the sweeping health care changes that were signed into law in March 2010. In general the new health care rules will require more companies to offer health care insurance to employees. McDonald's also homed in on a part in the law that would require more restaurants to add calorie information to their menus.
Elusys Therapeutics, Inc. today announced the U.S. Food and Drug Administration has accepted for filing and review its Biologics License Application for Anthim® (obiltoxaximab) for the treatment and prevention of inhalational anthrax, a top bioterror threat which was submitted on March 20, 2015. Anthim is a candidate for future acquisition into the Strategic National Stockpile, the U.S. government's repository of critical medical supplies for biowarfare preparedness.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that detailed data from its open-label Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH) will be presented at the 30th World Congress of the Société Internationale d'Urologie Conference.
› Verified 5 days ago
Tiffany Macaranas, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8125 Fletcher Grn, Buena Park, CA 90621 Phone: 714-249-0875 | |
Janice Eunjeong Jang, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5161 Beach Blvd #c, Buena Park, CA 90621 Phone: 714-228-9212 Fax: 714-228-9217 | |
Ms. Haesoon Yoon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4520 Beach Blvd, Buena Park, CA 90621 Phone: 714-523-2960 Fax: 714-994-2923 | |
Christopher Tri Ho, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7065 La Palma Ave, Buena Park, CA 90620 Phone: 714-228-2085 Fax: 714-690-7653 | |
Gordon Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8850 Valley View St, Buena Park, CA 90620 Phone: 714-827-7321 | |
Jaeeun Yoon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5230 Beach Blvd, Buena Park, CA 90621 Phone: 714-739-8811 |